1. Home
  2. GNFT vs EARN Comparison

GNFT vs EARN Comparison

Compare GNFT & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • EARN
  • Stock Information
  • Founded
  • GNFT 1999
  • EARN 2012
  • Country
  • GNFT France
  • EARN United States
  • Employees
  • GNFT N/A
  • EARN N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • EARN Real Estate Investment Trusts
  • Sector
  • GNFT Health Care
  • EARN Real Estate
  • Exchange
  • GNFT Nasdaq
  • EARN Nasdaq
  • Market Cap
  • GNFT 216.7M
  • EARN 189.7M
  • IPO Year
  • GNFT 2019
  • EARN 2013
  • Fundamental
  • Price
  • GNFT $4.16
  • EARN $5.13
  • Analyst Decision
  • GNFT Strong Buy
  • EARN Buy
  • Analyst Count
  • GNFT 2
  • EARN 2
  • Target Price
  • GNFT $10.00
  • EARN $5.88
  • AVG Volume (30 Days)
  • GNFT 10.8K
  • EARN 348.1K
  • Earning Date
  • GNFT 09-22-2025
  • EARN 11-11-2025
  • Dividend Yield
  • GNFT N/A
  • EARN 18.71%
  • EPS Growth
  • GNFT N/A
  • EARN N/A
  • EPS
  • GNFT N/A
  • EARN N/A
  • Revenue
  • GNFT $52,994,715.00
  • EARN $35,893,000.00
  • Revenue This Year
  • GNFT $3.14
  • EARN N/A
  • Revenue Next Year
  • GNFT N/A
  • EARN $15.96
  • P/E Ratio
  • GNFT N/A
  • EARN N/A
  • Revenue Growth
  • GNFT N/A
  • EARN 43.30
  • 52 Week Low
  • GNFT $2.55
  • EARN $4.33
  • 52 Week High
  • GNFT $6.42
  • EARN $7.11
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 53.72
  • EARN 34.17
  • Support Level
  • GNFT $3.93
  • EARN $5.01
  • Resistance Level
  • GNFT $4.28
  • EARN $5.13
  • Average True Range (ATR)
  • GNFT 0.17
  • EARN 0.12
  • MACD
  • GNFT 0.03
  • EARN -0.02
  • Stochastic Oscillator
  • GNFT 69.15
  • EARN 16.97

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

Share on Social Networks: